Cole-Parmer_Pharmabiz_web_2019
  Editorial
 END THIS DUAL CONTROL MESS   
 Wednesday, June 19, 2019 
 The pharmacy institutions as well as the aspiring pharmacy students in the country are once again in absolute confusion about who controls pharmacy education in the country, whether it is All India Council of Technical Education 
  Past Editorial...  
TODAY'S NEWS
17:10  [IST]Dr Reddy's Labs launches generic TOBI inhalation solution in US market
17:00  [IST]Researchers find C. auris an emerging fungal pathogen that causes large outbreaks in healthcare facilities
16:00  [IST]US FDA accepts and grants priority review status to GSK’s sNDA for Zejula in late stage ovarian cancer
15:00  [IST]Bruker showcases new phenomics research tools at Metabolomics 2019
14:45  [IST]MCOPS and CIMR organise programme on 'Ethnomedicine: An update 2019'
14:00  [IST]WHO introduces new tool ‘AWaRe’ and sets target to speed-up action against antimicrobial resistance
more news >>
TOP NEWS
08:00  [IST]Maharashtra FDA witnesses surge in new product approvals after initial hiccups following CDSCO mandated stability data
08:00  [IST]Proposal for provisioning ayurvedic drugs sale license in Drugs Act again goes for review to Maharashtra govt
08:00  [IST]Karnataka Homoeopathic Medical Association urges govt to open dedicated homoeo wings in all govt hospitals
08:00  [IST]CPhI global pharma event series continue to surge ahead in 2019
08:00  [IST]IPA's ‘Vision 2030’ report stresses on 7 strategic interventions by govt to take Indian pharma industry to US$ 120-130 billion by 2030
08:00  [IST]Bulk drugs park project at MIHAN, Nagpur still waiting for environmental clearance
more news >>
YESTERDAY'S NEWS
18:00  [IST]Bayer initiates phase III trial of Aflibercept to prevent blindness in premature infants
17:00  [IST]US FDA approves Amag Pharma's Vyleesi to treat HSDD in premenopausal women
16:00  [IST]Camurus receives US FDA approval to begin phase 3 study of CAM2029 for treatment of acromegaly
15:00  [IST]Vertex Pharma gets US FDA nod for Symdeko to treat underlying cause of CF in children ages 6-11 years with certain mutations in CFTR gene
14:20  [IST]Indian Immunologicals to invest Rs. 75 crore to expand Karkapatla plant in Telangana
14:10  [IST]Glenmark to promote, commercialize Novartis' 3 respiratory products to treat COPD in Brazil
more news >>
INTERVIEW  
Advanced flooring, integral part of pharma & healthcare infrastructure
Agradeep Mondal, Director Sales, Interface South Asia115398Agradeep
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Pharmatech-Expo-2019-Pharmabiz
CP: HI_Korea_2019_150x60
IPJ_2019_pharmabiz_150x60
Ipe_2019_150x 60
CPhI_Korea_2019_150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |